Why ACGT’s Work Matters More Than Ever – A Look At Glioblastoma After John McCain’s Passing

  • | Aug 30 2018 |

By Margaret C. Cianci

As many of you know, elder statesman Senator John McCain passed away this week at age 81 after his last battle – this one against glioblastoma, an insidious type of brain cancer.

Read More

Are there CAR T Cell Therapy Clinical Trials?

  • | Jul 31 2018 |

Currently, there are ongoing trials for Car T Cell therapy to treat different types of cancer. Before any trial is conducted, researches work endlessly for years to understand how the treatment works in a lab with animals.

Read More

Cancer Vaccines: Early Beginnings

  • | May 25 2017 |

At the ACGT anniversary gala in April, Robert Vonderheide, MD, DPhil, the Hanna Wise Professor in Cancer Research and newly appointed Director of the Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania,

Read More

CRISPR the Next Frontier in Gene Therapy Cancer Research

  • | Sep 06 2016 |

In our last blog, we described the progress and promise of CAR T, an immunotherapy that has been particularly successful with leukemia and lymphoma. As a companion to CAR T, and all forms of cell and gene therapies,

Read More

Witness to Cancer Research Progress

  • | Jul 27 2016 |

We recently participated in a webinar sponsored by FasterCures featuring highlights of the Cancer Moonshot Summit in Washington, D.C. You may recall the Moonshot is the initiative announced at President Obama’s State of the Union Address in January,

Read More